Gestational Trophoblastic Disease: Current Evaluation and Management
John T. Soper
Abstract
( Obstet Gynecol . 2021;137:355–370) Gestational trophoblastic disease (GTD) refers to rare disease processes originating from the placenta that require timely and appropriate management. GTD includes partial or complete hydatidiform moles (HM), as well as severe gestational trophoblastic neoplasia (GTN) and related tumors. Obstetrician-gynecologists are more likely to be involved in the care of women with HM or who have unclear diagnosis related to human chorionic gonadotropin (hCG).
Topics & Concepts
Gestational trophoblastic diseaseMedicineGestational trophoblastic neoplasiaHuman chorionic gonadotropinObstetricsGynecologyExpectant managementDiseasePlacentaPartial Hydatidiform MoleObstetrics and gynaecologyPlacental site trophoblastic tumorChoriocarcinomaGestationPlacenta DiseasesGonadotropinPregnancyFetusPathologyInternal medicineHormoneBiologyGeneticsGestational Trophoblastic Disease Studies